China approves first domestic Covid-19 vaccine for general use
Sinopharm claims 79% efficacy but concerns remain over lack of trial data transparency
Full Article
China approves first domestic Covid-19 vaccine for general use
FT.com
0 shares
1 views
You might like
Related news coverage
Covid-19: China approves Sinopharm vaccine for general use
The Sinopharm vaccine is the first in China to be approved beyond emergency use.
BBC News